ACCURACY: Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM) (Other)
Overall Status
Completed
CT.gov ID
NCT03815032
Collaborator
Opsens Medical (Other)
45
1
2
13.9
3.2

Study Details

Study Description

Brief Summary

The goal of the ACCURACY study is to assess the differences, if any, in FFR measurements made by the OptoWire Deux FFR guidewire by comparison of simultaneous data of two different OptoWire DeuxTM guidewires (group 1). In addition, the investigators will compare (group 2) the FFR measurements obtained from an OptoWire Deux FFR guidewire and compare it to the FFR measurement by a VERRATA-TM guidewire to assess coronary stenosis in the routine clinical practice.

Condition or Disease Intervention/Treatment Phase
  • Device: Drift assessment of OptoWire Deux FFR wire (1)
  • Device: Drift assessment of OptoWire Deux FFR wire (2)
N/A

Detailed Description

This is a single center, prospective, non-blinded clinical investigation enrolling consecutive patients with coronary lesion candidate for FFR assessment. The study aim to assess the differences, if any, in FFR measurements made by the OptoWire Deux FFR guidewire by comparison of simultaneous data of two different OptoWire DeuxTM guidewires (group 1, n=30). In addition, The investigators will compare (group 2, n=15) the FFR measurements obtained from an OptoWire Deux FFR guidewire and compare it to the FFR measurement by a VERRATA-TM guidewire to assess coronary stenosis in the routine clinical practice. The clinical investigation will be conducted in the Centre Hospitalier de l'Université de Montréal (CHUM). No clinical follow-up is requested after the end of the procedure.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison
Actual Study Start Date :
Feb 1, 2019
Actual Primary Completion Date :
Jan 30, 2020
Actual Study Completion Date :
Mar 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Optowire Deux FFR assessment (1)

A total of 45 consecutive patients will be recruited: group 1 (n=30): To assess the differences in FFR measurements (drift) made by the OptoWire Deux FFRTM guidewire by comparison of simultaneous data of two different OptoWire DeuxTM guidewires

Device: Drift assessment of OptoWire Deux FFR wire (1)
Simultaneous data of two different OptoWire DeuxTM guidewires (group 1) to assess a single coronary stenosis and detect any difference if any.

Experimental: Optowire Deux FFR assessment (2)

group 2 (n=15): To assess the differences in FFR measurements (drift) obtained from an OptoWire DeuxTM FFR guidewire and compare it to the FFR measurement by a VERRATATM guidewire

Device: Drift assessment of OptoWire Deux FFR wire (2)
Simultaneous data of one Optowire Deux TM guide wires and one VERRATA-TM FFR wire (group 2) to assess a single coronary stenosis and detect any difference if any.

Outcome Measures

Primary Outcome Measures

  1. delta FFR [Day 1]

    To assess the magnitude of reading delta from wire to wire in a percutaneous coronary intervention

Secondary Outcome Measures

  1. Drift recording [Day 1]

    The rate of significant drift, defined as Pd/Pa <0.97 or >1.03

  2. Delta from guidewire to guidewire [Day 1]

    Assess the magnitude of reading delta from guidewire to guidewire prior to equalization.

  3. Stents [Day 1]

    The number of stents used.

  4. Stents on FFR wire [Day 1]

    The number of stents placed over an OptoWire DeuxTM guidewire.

  5. Workhorse guidewire [Day 1]

    Number of Workhorse guidewire used.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Single de novo coronary lesion or in-stent restenosis lesion with an operator assessed reference diameter ≥2.0 mm requiring FFR measurement based on the operator's clinical judgment
Exclusion Criteria:
  • Patients with ST-segment-elevation myocardial infarction (STEMI), culprit lesion of non-ST-segment-elevation myocardial infarction (NSTEMI), New York Heart Association class IV heart failure, suspected or visible thrombus, dissection or excessive calcification or tortuosity in the target vessel, or a stenosis in a bypass graft will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier de l'Université de Montréal Montreal Quebec Canada H2X0C1

Sponsors and Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)
  • Opsens Medical

Investigators

  • Principal Investigator: Samer Mansour, MD, Centre hospitalier de l'Université de Montréal (CHUM)

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT03815032
Other Study ID Numbers:
  • 18.238
First Posted:
Jan 24, 2019
Last Update Posted:
Jul 20, 2020
Last Verified:
Jan 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2020